David Lamond, Director at Cortexyme, Inc. (CRTX), bought 98,250 shares at $42.13 ($4.3M) on 2020-06-04, disclosed to the SEC on 2020-06-08.
Open-market purchase of $4.3M CRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.13 | 13,609 | $573K | 13.5% |
| 2 | $42.13 | 13,609 | $573K | 13.5% |
| 3 | $43.32 | 10,642 | $461K | 10.8% |
| 4 | $43.32 | 10,642 | $461K | 10.8% |
| 5 | $43.88 | 24,874 | $1.1M | 25.7% |
| 6 | $43.88 | 24,874 |
| $1.1M |
| 25.7% |
| Total | $43.27 avg | 98,250 | $4.3M | 100% |
| Filing → |
| QNCX | BUY | 2023-12-01 | $41K | — | Filing → |
| QNCX | BUY | 2023-08-31 | $216K | — | Filing → |
| QNCX | BUY | 2023-08-17 | $620K | — | Filing → |